Literature DB >> 29517280

Index of cardiac electrophysiological balance and transmural dispersion of the repolarization index relationships with pericardial fat volume and coronary calcification.

Hussein Nafakhi1, Abdulameer A Al-Mosawi2, Mohammed Alareedh3, Hasan A Al-Nafakh2.   

Abstract

AIM: To assess the possible relationship between coronary atherosclerosis markers, pericardial fat volume (PFV) and coronary artery calcification, with ECG markers of index of the cardiac electrophysiological balance (iCEB) and transmural dispersion of the repolarization in patients with suspected coronary artery disease.
METHODOLOGY: One hundred patients who underwent 64-slice multidetector computed tomography angiography were found to be eligible and were enrolled in the study.
RESULTS: Patients with high iCEB levels tended to have a higher PFV values compared with patients with low iCEB levels (median [interquartile range]) (152 [29-206] vs 96 [14-177]; p = 0.03). No significant differences in coronary artery calcification values were observed between iCEB and transmural dispersion of the repolarization groups.
CONCLUSION: A higher PFV value was observed in patients with high iCEB. Larger prospective studies are required to confirm the results.

Entities:  

Keywords:  ECG markers; MDCT; TDR; coronary calcification; iCEB; pericardial fat

Mesh:

Year:  2018        PMID: 29517280     DOI: 10.2217/bmm-2017-0187

Source DB:  PubMed          Journal:  Biomark Med        ISSN: 1752-0363            Impact factor:   2.851


  2 in total

1.  Electrocardiographic markers of increased risk of sudden cardiac death in patients with COVID-19 pneumonia.

Authors:  Mohammed Alareedh; Hussein Nafakhi; Foaad Shaghee; Ahmed Nafakhi
Journal:  Ann Noninvasive Electrocardiol       Date:  2021-01-19       Impact factor: 1.485

2.  Evaluation of Tp-e interval, Tp-e/QT ratio and index of cardiac-electrophysiological balance in patients with tinnitus.

Authors:  Hakan Kaya; Arif Suner; Mehtap Koparal; S Cem Yucetas; Safiye Kafadar
Journal:  BMC Cardiovasc Disord       Date:  2021-08-30       Impact factor: 2.298

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.